甲状腺激素受体α和β突变揭示T3与T4识别分子决定因素
本研究基于一名对甲状腺激素抵抗(RTH)α患者中新发现的M256T突变,探究TRα1中Met256及TRβ1中对应残基Met310在区分T3与T4中的作用。结构建模显示TRα1-M256T突变对疏水口袋的扭曲对T3的影响大于T4,与模型一致,TRα1-M256T选择性降低了对T3的亲和力,且对T3与T4依赖的转录激活产生不同影响。TRα1-M256A和TRβ1-M310T突变体表现出类似的T3与T4差异。结论表明Met256-TRα1/Met310-TRβ1强烈增强TR对T3的亲和力,从而在很大程度上决定T3是生物活性激素而非T4。
要点
- TRα1-M256T突变选择性降低对T3的亲和力,对T4影响较小。
- Met256-TRα1/Met310-TRβ1强烈增强TR对T3的亲和力。
- 该残基是决定T3为生物活性激素的关键分子基础。
核心结论
- Met256-TRα1/Met310-TRβ1强烈增强TR对T3的亲和力,从而 largely 决定T3是生物活性激素而非T4。
研究设计与样本
- 对一名RTHα患者进行临床表征,并进行分子研究(计算机蛋白建模、放射性配体结合、反式激活和受体辅因子研究)。
主要发现
- TRα1-M256T突变体结构建模显示疏水口袋扭曲对T3的影响大于T4。
- TRα1-M256T选择性降低了对T3的亲和力。
- TRα1-M256T对T3与T4依赖的转录激活产生不同影响。
- TRα1-M256A和TRβ1-M310T突变体表现出类似的T3与T4差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The two major forms of circulating thyroid hormones (THs) are T3 and T4. T3 is regarded as the biologically active hormone because it binds to TH receptors (TRs) with greater affinity than T4. However, it is currently unclear what structural mechanisms underlie this difference in affinity. OBJECTIVE: Prompted by the identification of a novel M256T mutation in a resistance to TH (RTH)α patient, we investigated Met256 in TRα1 and the corresponding residue (Met310) in TRβ1, residues previously predicted by crystallographic studies in discrimination of T3 vs T4. METHODS: Clinical characterization of the RTHα patient and molecular studies (in silico protein modeling, radioligand binding, transactivation, and receptor-cofactor studies) were performed. RESULTS: Structural modeling of the TRα1-M256T mutant showed that distortion of the hydrophobic niche to accommodate the outer ring of ligand was more pronounced for T3 than T4, suggesting that this substitution has little impact on the affinity for T4. In agreement with the model, TRα1-M256T selectively reduced the affinity for T3. Also, unlike other naturally occurring TRα mutations, TRα1-M256T had a differential impact on T3- vs T4-dependent transcriptional activation. TRα1-M256A and TRβ1-M310T mutants exhibited similar discordance for T3 vs T4. CONCLUSIONS: Met256-TRα1/Met310-TRβ1 strongly potentiates the affinity of TRs for T3, thereby largely determining that T3 is the bioactive hormone rather than T4. These observations provide insight into the molecular basis for underlying the different affinity of TRs for T3 vs T4, delineating a fundamental principle of TH signaling.
引用
- Wejaphikul K, Groeneweg S, Hilhorst-Hofstee Y, et al. Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β. J Clin Endocrinol Metab. 2019. PMID: 30817817. doi:10.1210/jc.2018-02794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。